Mometasone Furoate Monohydrate Aurobindo (Mometasone Furoate)

Mometasone furoate works by binding to intracellular glucocorticoid receptors in nasal mucosal cells. This complex alters gene transcription, leading to decreased production of inflammatory mediators such as cytokines and prostaglandins, which in turn reduces swelling, mucus production, and allergic symptoms.

The prescribed dose is determined by the treating clinician based on the patient’s age, severity of symptoms, and response to therapy. Typical regimens involve one or two sprays per nostril once daily, but exact dosing should always follow the healthcare professional’s instructions.

Safety data for mometasone furoate in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mometasone furoate is a high‑potency intranasal corticosteroid with a low systemic bioavailability, similar to fluticasone propionate and budesonide. Compared with some alternatives, it may offer longer symptom control with once‑daily dosing, but clinical choice depends on individual response, tolerability, and physician preference.

Store the nasal spray at room temperature, preferably below 25 °C. Keep it in the original packaging to protect from moisture and direct sunlight. Do not freeze the product, and ensure the cap is tightly closed when not in use.

The medication is delivered as a nasal spray. Before use, gently shake the bottle, prime it if required, and tilt the head slightly forward. Insert the nozzle into one nostril, close the opposite nostril, and spray the prescribed number of sprays while breathing in gently. Repeat in the other nostril if directed.

Serious but rare risks include nasal septal perforation, severe allergic reactions such as anaphylaxis, and systemic effects like adrenal suppression when used for extended periods. Patients should seek immediate medical attention if they experience unusual nosebleeds, persistent pain, or signs of an allergic reaction.

Individuals with known hypersensitivity to mometasone furoate or any component of the formulation should avoid its use. It is also contraindicated in patients with active untreated fungal, bacterial, or viral infections of the nasal passages until the infection is resolved.